Malignant  	Malignant  	 JJ	B-NP
mixed  	mixed  	 JJ	O
tumors  	tumors  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
parotid  	parotid  	 JJ	B-NP
gland 	gland 	 NN	I-NP
:  	:  	 :	O
a  	a  	 DT	O
review  	review  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Department  	Department  	 NNP	O
of  	of  	 IN	O
Otolaryngology  	Otolaryngology  	 NNP	B-NP
Medical  	Medical  	 NNP	I-NP
University  	University  	 NNP	I-NP
of  	of  	 IN	I-NP
Warsaw  	Warsaw  	 NNP	I-NP
experience  	experience  	 FW	I-NP
Pleomorphic  	Pleomorphic  	 FW	I-NP
adenoma  	adenoma  	 FW	I-NP
( 	( 	 -LRB-	O
PA 	PA 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
benign  	benign  	 JJ	O
mixed  	mixed  	 JJ	O
tumor 	tumor 	 NN	B-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
the  	the  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
salivary  	salivary  	 JJ	B-NP
gland  	gland  	 JJ	I-NP
neoplasm 	neoplasm 	 NN	I-NP
.  	.  	 .	O
One  	One  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
factors  	factors  	 NNS	O
influencing  	influencing  	 VBG	O
the  	the  	 DT	O
management  	management  	 NN	B-NP
strategy  	strategy  	 NN	I-NP
in  	in  	 IN	O
parotid  	parotid  	 JJ	B-NP
PA  	PA  	 NNP	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
risk  	risk  	 NN	O
of  	of  	 IN	O
malignant  	malignant  	 JJ	O
transformation  	transformation  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
tumor 	tumor 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	O
and  	and  	 CC	O
pathological  	pathological  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	O
malignant  	malignant  	 JJ	O
mixed  	mixed  	 JJ	O
tumors  	tumors  	 NNS	O
treated  	treated  	 VBN	O
surgically  	surgically  	 RB	O
at  	at  	 IN	O
the  	the  	 DT	O
Department  	Department  	 NNP	O
of  	of  	 IN	O
Otolaryngology 	Otolaryngology 	 NNP	B-NP
,  	,  	 ,	O
Medical  	Medical  	 NNP	O
University  	University  	 NNP	O
of  	of  	 IN	O
Warsaw 	Warsaw 	 NNP	O
.  	.  	 .	O
Retrospectively  	Retrospectively  	 JJ	O
analysed  	analysed  	 JJ	O
clinical  	clinical  	 JJ	B-NP
material  	material  	 NN	I-NP
included  	included  	 VBD	O
12  	12  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
malignant  	malignant  	 JJ	O
mixed  	mixed  	 JJ	O
tumors  	tumors  	 NNS	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
423  	423  	 CD	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
underwent  	underwent  	 VBD	O
surgical  	surgical  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
for  	for  	 IN	I-NP
parotid  	parotid  	 JJ	I-NP
pleomorphic  	pleomorphic  	 JJ	I-NP
adenoma  	adenoma  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
Department  	Department  	 NNP	O
of  	of  	 IN	O
Otolaryngology 	Otolaryngology 	 NNP	B-NP
,  	,  	 ,	O
Medical  	Medical  	 NNP	O
University  	University  	 NNP	O
of  	of  	 IN	O
Warsaw 	Warsaw 	 NNP	O
,  	,  	 ,	O
between  	between  	 IN	O
January  	January  	 NNP	O
1988  	1988  	 CD	O
and  	and  	 CC	O
June  	June  	 NNP	O
2010 	2010 	 CD	O
.  	.  	 .	O
There  	There  	 EX	O
were  	were  	 VBD	O
7  	7  	 CD	O
women  	women  	 NNS	O
and  	and  	 CC	O
5  	5  	 CD	O
men 	men 	 NNS	O
;  	;  	 :	O
age  	age  	 NN	O
ranged  	ranged  	 VBD	O
from  	from  	 IN	O
39  	39  	 CD	O
to  	to  	 TO	O
67  	67  	 CD	O
years 	years 	 NNS	O
,  	,  	 ,	O
with  	with  	 IN	O
a  	a  	 DT	O
mean  	mean  	 NN	B-NP
of  	of  	 IN	O
56  	56  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
following  	following  	 JJ	O
parameters  	parameters  	 NNS	O
were  	were  	 VBD	O
analysed 	analysed 	 VBN	O
:  	:  	 :	O
demographic  	demographic  	 JJ	B-NP
data 	data 	 NNS	I-NP
,  	,  	 ,	O
symptoms  	symptoms  	 NNS	B-NP
and  	and  	 CC	O
disease  	disease  	 NN	B-NP
duration 	duration 	 NN	I-NP
,  	,  	 ,	O
results  	results  	 NNS	O
of  	of  	 IN	O
diagnostic  	diagnostic  	 JJ	B-NP
tests 	tests 	 NNS	I-NP
,  	,  	 ,	O
intraoperative  	intraoperative  	 JJ	B-NP
data 	data 	 NNS	I-NP
,  	,  	 ,	O
results  	results  	 NNS	O
of  	of  	 IN	O
histopathological  	histopathological  	 JJ	B-NP
examination 	examination 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
adjunctive  	adjunctive  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
Four  	Four  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
follow-up  	follow-up  	 JJ	O
shorter  	shorter  	 NN	O
than  	than  	 IN	O
5  	5  	 CD	O
years  	years  	 NNS	O
were  	were  	 VBD	O
excluded  	excluded  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	B-NP
results 	results 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
12  	12  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
malignant  	malignant  	 JJ	O
mixed  	mixed  	 JJ	O
tumours  	tumours  	 NN	O
included  	included  	 VBD	O
10  	10  	 CD	O
( 	( 	 -LRB-	O
83.3 	83.3 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
a  	a  	 DT	O
primary  	primary  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
and  	and  	 CC	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
16.7 	16.7 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
a  	a  	 DT	O
recurrent  	recurrent  	 JJ	O
tumor 	tumor 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
complete  	complete  	 JJ	O
study  	study  	 NN	B-NP
sample  	sample  	 NN	I-NP
( 	( 	 -LRB-	O
n=423 	n=423 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
malignant  	malignant  	 JJ	O
mixed  	mixed  	 JJ	O
tumor  	tumor  	 NN	B-NP
comprised 	comprised 	 NNS	O
:  	:  	 :	O
2.8 	2.8 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
2.5 	2.5 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
primary  	primary  	 JJ	B-NP
PA  	PA  	 NNP	I-NP
and  	and  	 CC	O
5.1 	5.1 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
recurrent  	recurrent  	 JJ	O
PA 	PA 	 NNP	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
with  	with  	 IN	O
malignant  	malignant  	 JJ	O
mixed  	mixed  	 JJ	O
tumor  	tumor  	 NN	B-NP
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
older  	older  	 JJR	O
than  	than  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
benign  	benign  	 JJ	O
PA  	PA  	 NNP	O
( 	( 	 -LRB-	O
an  	an  	 DT	O
average  	average  	 JJ	O
patient  	patient  	 NN	O
age  	age  	 NN	O
was  	was  	 VBD	O
56.0  	56.0  	 CD	O
and  	and  	 CC	O
43.2  	43.2  	 CD	O
years 	years 	 NNS	O
,  	,  	 ,	O
respectively  	respectively  	 RB	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.001 	0.001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
83.3 	83.3 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n=10 	n=10 	 NNP	O
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
older  	older  	 JJR	O
than  	than  	 IN	O
50  	50  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
An  	An  	 DT	O
average  	average  	 JJ	O
disease  	disease  	 NN	B-NP
duration  	duration  	 NN	I-NP
was  	was  	 VBD	O
longer  	longer  	 RBR	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
malignant  	malignant  	 JJ	O
tumors 	tumors 	 NNS	O
.  	.  	 .	O
Considering  	Considering  	 VBG	O
all  	all  	 DT	O
data  	data  	 NNS	O
from  	from  	 IN	O
preoperative  	preoperative  	 JJ	B-NP
patient  	patient  	 NN	I-NP
assessment  	assessment  	 NN	I-NP
( 	( 	 -LRB-	O
medical  	medical  	 JJ	B-NP
history 	history 	 NN	I-NP
,  	,  	 ,	O
physical  	physical  	 JJ	B-NP
examination 	examination 	 NN	I-NP
,  	,  	 ,	O
FNAB 	FNAB 	 NNP	B-NP
,  	,  	 ,	O
imaging  	imaging  	 JJ	O
studies 	studies 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
preliminary  	preliminary  	 JJ	B-NP
diagnosis  	diagnosis  	 NN	I-NP
of  	of  	 IN	O
malignant  	malignant  	 JJ	O
disease  	disease  	 NN	O
was  	was  	 VBD	O
made  	made  	 VBN	O
in  	in  	 IN	O
6  	6  	 CD	O
( 	( 	 -LRB-	O
50 	50 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
patients 	patients 	 NNS	O
.  	.  	 .	O
All  	All  	 DT	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
treated  	treated  	 VBN	O
surgically  	surgically  	 NNS	O
and  	and  	 CC	O
10  	10  	 CD	O
also  	also  	 RB	O
had  	had  	 VBD	O
radiation  	radiation  	 NN	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
n=8 	n=8 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
evaluation  	evaluation  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	B-NP
results 	results 	 NNS	I-NP
,  	,  	 ,	O
included  	included  	 VBD	O
three  	three  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
non-invasive  	non-invasive  	 JJ	B-NP
carcinoma  	carcinoma  	 NN	I-NP
and  	and  	 CC	O
five  	five  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
invasive  	invasive  	 JJ	B-NP
carcinoma 	carcinoma 	 NN	I-NP
.  	.  	 .	O
All  	All  	 DT	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
non-invasive  	non-invasive  	 JJ	B-NP
carcinoma  	carcinoma  	 NN	I-NP
were  	were  	 VBD	O
free  	free  	 JJ	O
from  	from  	 IN	O
disease  	disease  	 NN	B-NP
symptoms  	symptoms  	 NNS	I-NP
during  	during  	 IN	O
the  	the  	 DT	O
follow-up  	follow-up  	 JJ	O
of  	of  	 IN	O
9  	9  	 CD	O
to  	to  	 TO	O
21  	21  	 CD	O
years  	years  	 NNS	O
after  	after  	 IN	O
the  	the  	 DT	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
Five-year  	Five-year  	 JJ	B-NP
survival  	survival  	 NN	I-NP
was  	was  	 VBD	O
80 	80 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
4  	4  	 CD	O
of  	of  	 IN	O
5  	5  	 CD	O
patients 	patients 	 NNS	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
a  	a  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
invasive  	invasive  	 JJ	B-NP
carcinoma 	carcinoma 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
rate  	rate  	 NN	O
of  	of  	 IN	O
death  	death  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
underlying  	underlying  	 JJ	O
disease  	disease  	 NN	O
was  	was  	 VBD	O
the  	the  	 DT	O
same  	same  	 JJ	O
( 	( 	 -LRB-	O
80 	80 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
An  	An  	 DT	O
overall  	overall  	 JJ	O
5-year  	5-year  	 CD	O
survival  	survival  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
malignant  	malignant  	 JJ	O
mixed  	mixed  	 JJ	O
tumor  	tumor  	 NN	B-NP
was  	was  	 VBD	O
87.5 	87.5 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
1 	1 	 LS	O
.  	.  	 .	O
Malignant  	Malignant  	 JJ	B-NP
transformation  	transformation  	 NN	I-NP
of  	of  	 IN	I-NP
pleomorphic  	pleomorphic  	 JJ	I-NP
adenoma  	adenoma  	 NN	I-NP
more  	more  	 RBR	O
frequently  	frequently  	 RB	O
occurs  	occurs  	 VBZ	O
in  	in  	 IN	O
recurrent  	recurrent  	 JJ	O
tumors  	tumors  	 NNS	O
and  	and  	 CC	O
in  	in  	 IN	O
older  	older  	 JJR	O
patients.  	patients.  	 CD	O
2 	2 	 CD	O
.  	.  	 .	O
Uncharacteristic  	Uncharacteristic  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
picture  	picture  	 NN	I-NP
of  	of  	 IN	O
malignant  	malignant  	 JJ	O
mixed  	mixed  	 JJ	O
tumors  	tumors  	 NN	O
allows  	allows  	 VBZ	O
to  	to  	 TO	O
make  	make  	 VB	O
an  	an  	 DT	O
accurate  	accurate  	 JJ	O
initial  	initial  	 JJ	O
diagnosis  	diagnosis  	 NN	O
only  	only  	 RB	O
in  	in  	 IN	O
half  	half  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
patients.  	patients.  	 CD	O
3 	3 	 CD	O
.  	.  	 .	O
Extracapsular  	Extracapsular  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
invasion  	invasion  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
vital  	vital  	 JJ	O
prognostic  	prognostic  	 JJ	B-NP
factor 	factor 	 NN	I-NP
.  	.  	 .	O
Overall  	Overall  	 RB	O
5-year  	5-year  	 CD	O
survival  	survival  	 NN	O
for  	for  	 IN	O
invasive  	invasive  	 NN	O
and  	and  	 CC	O
noninvasive  	noninvasive  	 JJ	B-NP
carcinoma  	carcinoma  	 NN	I-NP
was  	was  	 VBD	O
80  	80  	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
100  	100  	 CD	O
%  	%  	 NN	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
